Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112559 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Ruyu Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China; Guangdong Provi…. Hauptthemen laut MEDLINE: Endometriosis, Semaphorin-3A, Macrophages, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Semaphorin 3A (Sema3A) is a member of neural guidance factor family well-known for inducing the collapse of nerve cell growth cone and regulating nerve redistribution. It also has been characterized as an immunoregulatory and tumor promoting factor. Our previous study showed that Sema3A was involved in the regulation of sympathetic innervation and neuropathic pain of endometriosis. Nevertheless, the role of Sema3A in the development of endometriosis and its potential upstreaming factor are still not clear. METHODS: Histology experiments were carried to detect the expression of Sema3A, hypoxia -inducible factor 1α (HIF-1α) and the distribution of macrophages. Cell experiments were used to explore the effect of Sema3A on the proliferation and migration of endometrial stromal cells (ESCs) and to confirm the regulatory action of HIF-1α on Sema3A. In vivo experiments were carried out to explore the role of Sema3A on the development of endometriosis. RESULTS: Sema3A was highly expressed in endometriotic lesions and could enhanced the proliferation and migration abilities of ESCs. Aberrant macrophage distribution was found in endometriotic lesions. Sema3A also promoted the differentiation of monocytes into anti-inflammatory macrophages, so indirectly mediating the proliferation and migration of ESCs. Hypoxic microenvironment induced Sema3A mRNA and protein expression in ESCs via HIF-1α. Administration of Sema3A promoted the development of endometriosis in a mouse model. CONCLUSIONS: Sema3A, which is regulated by HIF-1α, is a promoting factor for the development of endometriosis. Targeting Sema3A may be a potential treatment strategy to control endometriotic lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, China; Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Disea…
- Department of Obstetrics and Gynecology, Jieyang People's Hospital (Jieyang Affiliated Hospital, Sun Yat-sen University), Jieyang 522081, Guangdong, China.
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
Zitieren
APA
Yang, R., Yang, F., Wei, Y., Huang, B., Cao, T., Tan, H., Liu, D., Zou, Q., Wen, J., Wen, L., Lu, X., Yu, C., Cai, H., Xie, X., Jiang, S., Yao, S., & Liang, Y. (2024). Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112559
Vancouver
Yang R, Yang F, Wei Y, Huang B, Cao T, Tan H, et al. Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112559
BibTeX
@article{Yang2024,
author = {Yang, Ruyu and Yang, Fan and Wei, Yajing and Huang, Biqi and Cao, Tiefeng and Tan, Hao and Liu, Duo and Zou, Qiuyu and Wen, Jinjuan and Wen, Lei and Lu, Xi and Yu, Changyang and Cai, Heng and Xie, Xiaofei and Jiang, Shaoru and Yao, Shuzhong and Liang, Yanchun},
title = {Hypoxia-induced Semaphorin 3A promotes the development of endometriosis through regulating macrophage polarization},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112559}
}
EUVIMED